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Abstract
Introduction The purpose of this study was to investigate the
radioligand uptake and iodine contrast distribution in the intra-
and extracranial circulation of the rat, after intra-arterial injec-
tions to the common carotid artery and different parts of the
internal carotid artery.
Methods All animal experiments were carried out in accor-
dance with Karolinska Institutet’s guidelines and were ap-
proved by the local laboratory animal ethics committee. We
used clinical neurointerventional systems to place
microcatheters in the extra- or intracranial carotid artery of
15 Sprague–Dawley rats. Here, injection dynamics of iodine
contrast was assessed using digital subtraction angiography.
Maintaining the catheter position, the animals were placed in a
micro PET and small-animal positron emission tomography
(PET) was used to analyze injections [2-18F]-2-fluoro-2-de-
oxy-D-glucose (18F-FDG).
Results Microcatheters had to be placed in the intracranial
carotid artery (iICA) for the infusate to distribute to the brain.
Selective injection via the iICA resulted in a 9-fold higher
uptake of 18F-FDG in the injected hemisphere (p<0.005)
compared to both intravenous and more proximal carotid
artery injections. Furthermore, selective injection gave a
dramatically improved contrast between the brain and extra-
cranial tissue.
Conclusion Intra-arterial injection increases the cerebral up-
take of a radiotracer dramatically compared to systemic injec-
tion. This technique has potential applications for endovascular
treatment of malignancies allowing intra-interventional modi-
fications of injection strategy, based on information on tumor
perfusion and risk to surrounding normal parenchyma. Further-
more the technique may increase diagnostic sensitivity and
avoid problems due to peripheral pharmacological barriers
and first passage metabolism of labile tracers.
Keywords Intra-arterial . Endovascular intervention .
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Introduction
Imaging by positron emission tomography (PET) is today an
expanding area of experimental and clinical investigations.
The development of suitable radiotracers is a crucial factor
for this expansion. Currently, radiotracers are primarily de-
signed for intravenous administration. Among the criteria they
need to meet are ability to reach and penetrate tissues contain-
ing the targets of interest, high affinity for the target, low non-
specific binding and limited or measurable metabolism out-
side the targeted tissue. However, an ability to perform organ-
selective administrations could fundamentally alter some of
these requirements.
Parallel to the development of PET, endovascular
neurointerventional procedures monitored with fluoroscopy
and digital subtraction angiography (DSA) have developed
to become standard care for a variety of diseases. The tech-
nique allows selective navigation to virtually all regions of the
vascular system, including the human brain. Implementation
of these procedures in nuclear medicine would make it
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possible to inject radiotracers selectively to targeted regions of
interest and thereby bypass many pharmacological hinders to
efficient tracer delivery.
Radiotracer-based imaging has occasionally been used to-
gether with interventional radiology (IR) to order to, for
example, optimize flow rates of carotid drug infusions [1]
and monitor regional depositions of chemotherapeutics
[2–5]. IR has clinically been combined with single-photon
emission computed tomography (SPECT) in brachytherapy
of the liver to guide the IA administration and avoid non-target
radiation [6, 7]. Inadvertent intra-arterial administration of
[2-18F]-2-fluoro-2-deoxy-D-glucose (18F-FDG) has anecdotal-
ly been reported to augment tracer uptake [8, 9]. However, no
study has been performed to investigate the possible advan-
tages of intra-arterial administration of 18F-FDG on its uptake
in targeted tissue. This study was undertaken to investigate
how injections of 18F-FDG in different locations of the arteries
supplying the rat brain would affect tracer uptake and distri-
bution. We hypothesize that the combination of PET, and
probably other nuclear medicine techniques, with
endovascular interventional systems may increase the value
and versatility of this radiotracer as well as other existing or
coming radiotracers for clinical use.
Materials and methods
All animal experiments were carried out in accordance with
Karolinska Institutet’s guidelines and were approved by the
local laboratory animal ethics committee (N337/10). Fifteen
adult male Sprague–Dawley rats (350–400 g) were permitted
food and water ad libitum until surgery. Anesthesia was in-
duced using 4 % isoflurane mixed with 96 % O2 and subse-
quently maintained at 2 % isoflurane. Animals were placed on
a heating pad and were kept normothermic. Arterial access
and endovascular navigation to the carotid artery were per-
formed as described previously, using a 0.40-mm (0.0157 in.
microcatheter (Sonic; Balt Extrusion, Montmorency, France)
carrying a 0.18-mm (0.007 in. microwire (Hybrid; Balt Ex-
trusion) microcatheter [10].
Digital subtraction angiography
We placed the microcatheter tip at three different positions,
one position in two each of the animals: (1) in the common
carotid artery (CCA), (2) in the cervical internal carotid
(cICA) although proximal to the branching of the
pterygopalatine artery (PPA), (3) distal to the PPA in the
intracranial part of the internal carotid artery (iICA). In these
different positions, we performedDSAvia injections of 100μl
iohexol (Omnipaque; Amersham Health; 180 mg/ml of io-
dine). The images were analyzed using OsiriX imaging soft-
ware (OsiriX Foundation).
Intra-arterial injections of 18F-FDG
The 18F-FDG used was an aliquot obtained from daily pro-
ductions for clinical PET at the Karolinska University Hospi-
tal and had passed all quality requirements for administrations
in humans. Using the same catheterization protocol as de-
scribed above, the microcatheter tip was positioned in the
CCA (n=3 animals) and in the iICA (n=3 animals). 18F-
FDG (10–20 MBq, 500 μl) followed by a saline flush of
300 μl was injected in each animal at a rate of 0.125 ml/
min. In three additional animals, 18F-FDGwas injected via the
tail vein.
Imaging and data analysis
In vivo PET investigations were performed on a MicroPET
Focus 120 (CTI Concorde Microsystems). PET data were
processed with MicroPET manager and evaluated using the
Inveon Research Workplace (Siemens Medical Solutions)
software. Data were collected continuously from the time of
injection for 25 min and were corrected for random, dead time
and decay. Images were reconstructed by standard 2D filtered
back projection using a ramp filter. Regions of interest were
drawn manually to cover cortical areas supplied by the ICA.
Statistical methods
The SPSS statistical packet (SPSS Mac OS X version 21,
SPSS Inc., Chicago, IL, USA) was used for the calculations.
Radioactivity levels in cerebral hemispheres at 25 min after
injection were compared using analysis of variances
(ANOVA), followed by Tukey's post hoc test. Any p value
<0.05 was considered significant.
Results
Selective intra-arterial injection of 18F-FDG
Injections of 18F-FDG were performed with the tip of the
microcatheter located in the CCA (n=3), in the iICA (n=3)
or in the tail vein (n=3). Catheter tip placement in the CCA
resulted in a markedly more intense uptake of 18F-FDG in the
ipsilateral extra- and intracranial tissues compared to contra-
lateral tissues (Figs. 1d and 2b, e). With this catheter position,
the uptake was most prominent in the extracranial compart-
ment (Fig. 1d); the anatomical distribution of the tracer was
identical to the opacification following injections of iodine
contrast in the CCA, showing that intra-arterial injection in
this location resulted in distribution predominantly in the
extracranial space (Fig. 1c, d). However, even with this cath-
eter position, the uptake in the hemisphere ipsilateral to the
injection tended to be higher than the uptake in the
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contralateral hemisphere, although without reaching signifi-
cant difference at equilibrium (Fig. 2b, e). On the other hand,
placement of the catheter tip in the iICA resulted in an intense
uptake in the left cerebral hemisphere only, corresponding to
9.2 times higher uptake compared to the CCA injection at
equilibrium after 25 min (p=0.009) (Figs. 1b and 2a, d, g).
Also, when comparing the ipsilateral cerebral hemisphere to
the contralateral hemisphere after iICA injection, the differ-
ence was 9.2 times higher (p=0.008) (Fig. 2a, d, g). The areas
with high uptake corresponded to the cortical areas supplied
by the iICA (Fig. 2a, d). The cerebral uptake of 18F-FDG after
iv injection was 8.69 times lower than after the iICA injection
(p=0.004) (Fig. 2a, c, d, f, g). Extra-cranial 18F-FDG uptake was
lower after iICA and CCA injections than after the iv injection
(Fig. 2a–f). Systemic uptake levels were higher after the CCA
injection than after the iICA injection, consistent with a higher
extraction of 18F-FDG in the brain compared to soft tissue
(Fig. 2a, b, d, e).
Injections of iodine contrast media to the carotid artery
DSA of the CCA and its branches confirmed the already well
defined anatomy of the external carotid artery (ECA), the cICA,
the iICA and the PPA of the rat [11] (Fig. 2a, d). The approx-
imate relative diameters of the CCA:ECA:cICA:iICA:PPA
were in concordance with anatomic studies [11], i.e.,
1.0:0.8:0.7:0.5:0.5, respectively. Injections of iodine contrast
media in the CCA resulted in reproducible opacification of the
ECA and PPA territories whereas opacification of the iICAwas
intermittent and weaker than the ECA and PPA (Fig. 1c).
Similarly, iodine contrast media injections in the cICA resulted
in reproducible opacification of the PPAwhereas opacification
of the iICA territory was intermittent and weaker than the PPA.
Injections directly in the iICA branch, however, resulted in
robust and reproducible opacification of cortical territories,
clearly showing the anatomy of the intracerebral arterial
branches (Fig. 1a). Thus, for administering contrast media
(and other substances) selectively to the brain itself, it was
necessary to position the catheter tip in the iICA (distal to the
PPA).
Discussion
In this paper, we suggest a combination of PET and the
endovascular neurointerventional suite to provide intra-
procedural nuclear medicine imaging during or after selective
intra-arterial injection of a radioligand. We used the most
commonly used clinical radiotracer 18F-FDG with a high
utilization in the brain, so the consequences of intra-arterial
administration at different positions in the carotid vessel could
be readily visualized. The main determinants for a sensitive
and specific PET visualization of CNS pathology are the
radiotracer properties, the local concentrations and the prolif-
erative, metabolic and receptor state of the target tissue. The
radiotracer needs to provide a clear contrast between normal
Fig. 1 Distribution of 18F-FDG
and iodine contrast media
following selective intra-arterial
injections in the internal and
common carotid arteries. aDigital
subtraction angiography (DSA)
and b 18F-FDG PET, following
injection in the left internal
carotid artery (iICA), showing
perfusion and uptake in the left
hemisphere. c DSA and d 18F-
FDG PET, following injection in
the left common carotid artery,
showing perfusion of extra- and
intracranial vasculature and 18F-
FDG distributions, respectively.
PET images are volume-
rendering technique 3D
projections and are summed over
25 min
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and pathological tissues even in situations when the patholog-
ic tissue has poor blood perfusion, altered membrane diffu-
sion, blood–brain barrier (BBB) breakdown or aberrant me-
tabolism. At the same time, the administered amounts of
radioactivity must be kept at as low as reasonably possible,
especially when using therapeutic radionuclides, whose off-
target tissue expositions can be dose limiting. We show that
selective intra-arterial injection of 18F-FDG resulted in a factor
of 9 increase in tracer uptake in the targeted tissue com-
pared to intravenous injection and also compared to less
selective intra-arterial administrations.
We started with analyzing the dynamics of injecting iodine
contrast in different positions of the carotid artery. In the rat,
the CCA directs blood flow to the extracranial circulation to a
larger extent than in man [11]. Furthermore, internal carotid
injection dynamics involve streaming of the infusate that
results in heterogeneous delivery to the regions supplied by
the carotid artery [12]. We show that injections at a slow rate
in the CCA or the proximal part of the internal carotid artery,
before the origin of the pterygopalatine artery, result in stream-
ing of the major part of the infusate to the extracranial circu-
lation. This finding emphasizes the need to consider un-
voluntary heterogeneous delivery to the rat brain as a result
of streaming phenomena when injecting radiotracers or other
substances in more proximal parts of the carotid artery. On the
other hand, selective administration via the microcatheter
placed in the iICA gave a robust exposure of radiotracer and
other agents to the vascular bed of the brain.
Increased local uptake of 18F-FDG following unintentional
intra-arterial injections to the forearm in patients was docu-
mented by Kumar in 2009 [8] and reviewed by Zhu et al. in






Fig. 2 Distribution and changes
in tissue radioactivity of 18F-FDG
following selective intra-arterial
injections in the internal and
common carotid arteries and
systemic injections in the tail
vein. 18F-FDG PET, transaxial
and coronal planes, following: a,
d injection in the left internal
carotid artery (iICA); b, e
injection in the common carotid
(CCA); c, f injection in the tail vein.
g Changes in tissue radioactivity
over time expressed as percentage
of the injected dose per gram
tissue (%ID/g; Yaxis=log10 mean
%ID/g) following: injection in the
iICA in the left (ICA LH, red dot)
and the right (ICA RH, purple
square) cerebral hemispheres;
following injection in the left
CCA in the left (CCA LH, green
triangle) and the right (CCA RH,
yellow inverted triangle) cerebral
hemispheres; following i.v.
injection (IV, blue rhombus). The
differences in mean values at
25 min are significant between
ICA LH and ICA RH (p=0.009),
ICA LH and CCA LH (p=0.008)
and between ICA LH and IV
(p=0.004). PET images are
summed over 25 min. Error
bars indicate ±1 SD
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uptake following intra-arterial injections to the brain com-
pared to intravenous injections have not been described pre-
viously. In this paper we demonstrate the intra- and extracra-
nial tissue distribution of 18F-FDG following intra-arterial
injections in different parts of the carotid arterial tree. We
show that it is possible to enhance the uptake of 18F-FDG by
a factor of nine in the brain by intra-arterial injection and
dramatically improve the contrast between brain and extracra-
nial tissues. The findings of this paper are intriguing, given the
advancements of endovascular interventional neuroradiology
in the treatment of acute stroke in recent years [13] and the
potential for using 18F-FDG as a diagnostic tool in brain
ischemia [14]. Previously, PET has been used to evaluate the
pharmacokinetic advantages of intra-arterial chemotherapy to
malignant brain tumors [2, 3]. Currently, superselective cere-
bral infusions of monoclonal antibody therapies are evaluated
in the treatment of malignant gliomas (MG) [15]. Preoperative
determination of perfused areas in MG by SPECT has been
shown to be useful [16]. Intra-arterial chemotherapy has re-
cently emerged as a safe and feasible procedure for eye-
conservingmanagement of retinoblastoma [17–19]. However,
superselective catheterization of and drug delivery in end-
arteries to the CNS require rigorous training and preparation.
This model may serve as a simulation of microcatheter han-
dling and evaluation of different injection techniques. Also for
neuroscience and psychiatric research, and maybe treatment,
the possibility to selectively administer a ligand to different
sub-lobar compartments of the brain could be an important
tool. In general, the principle of superselectively administer-
ing a wide range of radioligands could markedly increase the
sensitivity and resolution of nuclear medicine studies in di-
verse diagnostic and therapeutic approaches. One major ob-
stacle in molecular MRI is the weakness of conventional
contrast agents in relation to some molecular epitopes. Inter-
ventional techniques may be a useful tool to overcome this
problem by selective administration of targeted nanoparticles
under MRI [20, 21]. For studies requiring radiotracers that
undergo an important first passage metabolism in, for exam-
ple, the liver, this principle could be of utmost importance, as
we have recently demonstrated using these techniques [22].
Conclusion
We investigated radioligand uptake in the brain after intra-
arterial injections to the CCA and different parts of the internal
carotid artery. We show that the intra-arterial injection of 18F-
FDG results in markedly different hemispheric uptakes in the
brain compared to intravenous delivery and that the exact
intra-arterial catheter tip location in the vascular system has
important implications for the parenchymal uptake of 18F-
FDG. We believe that the combination of nuclear medicine
and endovascular interventional techniques could be of use in
superselective cytostatic delivery to brain tumors, where intra-
interventional radioligand administration would give informa-
tion on injection selectivity of tumor tissue versus normal
parenchyma exposure. Intra-arterial techniques may also
make the development of new radiopharmacons possible,
leading to new applications in imaging neurological and other
diseases. It may be possible to decrease the total dose of a
given radiotracer while dramatically increasing the local con-
centration. This is of importance when using therapeutic ra-
dionuclides, whose off-target tissue expositions can be dose-
limiting.
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